Walgreens Boots Alliance Inc (WBA) Holdings Reduced by Sentry Investment Management LLC

Sentry Investment Management LLC cut its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 34.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 69,753 shares of the pharmacy operator’s stock after selling 36,059 shares during the quarter. Sentry Investment Management LLC’s holdings in Walgreens Boots Alliance were worth $5,065,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of WBA. IPG Investment Advisors LLC increased its holdings in shares of Walgreens Boots Alliance by 15.8% in the fourth quarter. IPG Investment Advisors LLC now owns 95,781 shares of the pharmacy operator’s stock worth $6,956,000 after purchasing an additional 13,095 shares during the last quarter. Heritage Investors Management Corp increased its holdings in shares of Walgreens Boots Alliance by 159.3% in the fourth quarter. Heritage Investors Management Corp now owns 89,890 shares of the pharmacy operator’s stock worth $6,528,000 after purchasing an additional 55,230 shares during the last quarter. Ffcm LLC increased its holdings in shares of Walgreens Boots Alliance by 21.4% in the fourth quarter. Ffcm LLC now owns 38,120 shares of the pharmacy operator’s stock worth $2,768,000 after purchasing an additional 6,723 shares during the last quarter. Candriam Luxembourg S.C.A. increased its holdings in shares of Walgreens Boots Alliance by 7.4% in the fourth quarter. Candriam Luxembourg S.C.A. now owns 80,030 shares of the pharmacy operator’s stock worth $5,812,000 after purchasing an additional 5,511 shares during the last quarter. Finally, Wealth Advisors of Tampa Bay LLC bought a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth about $1,696,000. 61.57% of the stock is currently owned by institutional investors and hedge funds.

In related news, insider Stefano Pessina purchased 98,858 shares of the company’s stock in a transaction that occurred on Monday, January 15th. The stock was bought at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 14.80% of the company’s stock.

Several brokerages have recently issued reports on WBA. Zacks Investment Research cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Monday, January 22nd. Mizuho set a $87.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Wednesday, January 24th. ValuEngine cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Friday, February 2nd. Loop Capital set a $90.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Wednesday, January 3rd. Finally, Evercore ISI began coverage on Walgreens Boots Alliance in a report on Thursday, January 4th. They issued an “outperform” rating and a $80.00 target price on the stock. Ten equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $85.05.

Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $69.78 on Friday. The company has a market capitalization of $69,130.00, a PE ratio of 19.28, a P/E/G ratio of 1.15 and a beta of 1.18. Walgreens Boots Alliance Inc has a 12-month low of $63.82 and a 12-month high of $88.00. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The company had revenue of $30.74 billion during the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The firm’s revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the business posted $1.10 earnings per share. analysts expect that Walgreens Boots Alliance Inc will post 5.73 EPS for the current year.

Walgreens Boots Alliance declared that its Board of Directors has initiated a stock buyback plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.

The business also recently declared a quarterly dividend, which will be paid on Monday, March 12th. Investors of record on Thursday, February 15th will be given a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, February 14th. This represents a $1.60 annualized dividend and a yield of 2.29%. Walgreens Boots Alliance’s dividend payout ratio is currently 44.20%.

TRADEMARK VIOLATION WARNING: “Walgreens Boots Alliance Inc (WBA) Holdings Reduced by Sentry Investment Management LLC” was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this article on another domain, it was illegally copied and republished in violation of international copyright legislation. The correct version of this article can be accessed at https://stocknewstimes.com/2018/02/16/walgreens-boots-alliance-inc-wba-holdings-reduced-by-sentry-investment-management-llc.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply